Health Condition 1: null- ï?µ Eighty (80) patients with MSD, meeting all inclusion/exclusion criteria will be included in the study
Conditions
Interventions
Intervention1: Contrapain Lepa and Oil: Lepa powder contains drugs like Sigru, Punarnava, Kunduru, Rasna, Daruharidra, Shunthi, Lodhra, Devadaru,Nausadara, Chitraka, Sphatika
Oil contains NirgundiPat
Sponsors
MB Life Scienes Pvt Ltd New Delhi
Eligibility
Inclusion criteria
Inclusion criteria: Patients with musculoskeletal pain and swelling, fulfilling the diagnostic criteria of MS, willing to give consent for participating in the study. Patients who are currently on analgesics/NSAID, will be given a washout period of 7days prior to recruitment
Exclusion criteria
Exclusion criteria: Patients having severe MSD, those who are suffering from dermatitis or had a history of dermatitis, pregnant and lactating women, any other conditions which in the opinion of investigator will places the subject at risk or will influence the conduct of study or interpretation of results
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Before and after the treatment period of 7 days Changes in following parameters between day 1 and day 7: â?¢ Subjective parameters: Pain (VAS), Tenderness, Shotha (swelling/Inflammation), Stabdata (Stiffness), Physician Global Assessment â?¢ Objective parameters: Range of Motion (Goniometer) At screening: RA, CRP, Serum Uric acid Safety Parameters: CBC, LFT, RFT (base line and 7th day) (Only 50% of Patients) Timepoint: Day 0, 8, 22,37 | — |
Secondary
| Measure | Time frame |
|---|---|
| Assessment of subsidence after treatment period during the follow-up period up to 30 days. Subjective parameters will be assessed on day 15th and 30th day Timepoint: Day0, 8, 22 and 37 | — |
Countries
India
Contacts
Public ContactDrPradeep L Grampurohit
KLEUs Shri BMK Ayurveda Mahavidyalaya, Belagavi
Outcome results
None listed